Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00042107 · ClinicalTrials.gov registry record
Molecular Epidemiology of Parkinson's Disease
A clinical trial, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- Completed
- Registry status
- 2,022
- Enrollment target
NCT00042107: Completed study, sponsored by National Institute of Environmental Health Sciences (NIEHS).
NCT00042107 is a clinical trial that has completed, run by National Institute of Environmental Health Sciences (NIEHS). The registered enrollment target is 2,022 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00042107 has completed, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- COMPLETED
- Registry status
- 2,022 participants
- Enrollment target
Study Summary
The aim of this research is to discover genes which modify risk for Parkinson's disease. The study includes 800 patients with Parkinson's disease, and their estimated 1,222 available siblings. Common variations of at least 9 genes will be studied, including genes associated with personality, substance use, and anxiety and depression.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,022 participants |
| Start Date | 2000-09 |
| Est. Completion | 2005-06 |
What the finished NCT00042107 record still lists
NCT00042107 is an observational study that tracks outcomes without assigning an intervention. Its 2,022 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00042107 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00042107 about?
NCT00042107 is a clinical study titled "Molecular Epidemiology of Parkinson's Disease". The aim of this research is to discover genes which modify risk for Parkinson's disease. The study includes 800 patients with Parkinson's disease, and their estimated 1,222 available siblings. Common variations of at least 9 genes will be studied, including genes associated with personality, substan...
What is the current status of trial NCT00042107?
This trial is currently completed. The enrollment target is 2,022 participants. The study started on 2000-09. Estimated completion is 2005-06.
Who is sponsoring clinical trial NCT00042107?
This trial is sponsored by National Institute of Environmental Health Sciences (NIEHS), which has 145 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05059444 · 2,020 participants
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- NCT04216732 · 2,030 participants
Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management
- NCT05625659 · 2,032 participants · NA
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
- NCT04604509 · 2,010 participants · Phase 4
Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia